Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Clarification On Increase In Volume

 With reference to above mentioned subject, we write to inform that our company has been notifying to the stock exchanges all the events, information which comes under the purview of Regulation 30 of SEBI (LODR) Regulations, 2015 from time to time. At this point of time we do not have any material announcement/ event due for notification to the stock exchanges under Regulation 30 of SEBI LODR Regulations which may have a bearing on the price or volume behavior of the scrip. The increase in the price/volume of our security in the recent past appears to be based on market speculation and we have no other comment to offer on this development. We request you to disseminate this clarification on your website for information of general public, which is also being uploaded on our Company's website.
01-04-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Clarification sought from Suven Life Sciences Ltd

 The Exchange has sought clarification from Suven Life Sciences Ltd on April 1, 2022, with reference to Movement in Volume.The reply is awaited.
01-04-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Shareholding for the Period Ended March 28, 2022

 Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 28, 2022. For more details, kindly Click here
30-03-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property & Equity Holdings Pvt Ltd
29-03-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Allotment

 In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, we wish to inform that, the Board of Directors of the Company at its meeting held today i.e. 28th March, 2022 has approved the conversion of 1,81,00,000 fully paid warrants and issued & allotted 1,81,00,000 (One crore eighty one lakh) Equity Shares of Rs.1/- each to 'Jasti Property and Equity Holdings Private Limited (In its capacity as sole trustee of Jasti Family Trust)', promoter group entity at an issue price of Rs. 81.57/- per share on preferential basis in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
28-03-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Outcome for Allotment Of 18100000 Equity Shares Of The Company On Preferential Basis Upon Conversion 18100000 Fully Paid Warrants

 In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, we wish to inform that, the Board of Directors of the Company at its meeting held today i.e. 28th March, 2022 has approved the conversion of 1,81,00,000 fully paid warrants and issued & allotted 1,81,00,000 (One crore eighty one lakh) Equity Shares of Rs.1/- each to 'Jasti Property and Equity Holdings Private Limited (In its capacity as sole trustee of Jasti Family Trust)', promoter group entity at an issue price of Rs. 81.57/- per share on preferential basis in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
28-03-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received email communication from the following shareholders(s) regarding loss of share certificate(s). A copy of intimation letter enclosed herewith. This is for your information and record.
07-03-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Un-audited Financial Results of the Company for quarter ended 31st December, 2021. The advertisements are as appeared on 1st February, 2022 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at http://www.suven.com/newspaperads.aspx.
01-02-2022

Suven Life Sci Consolidated December 2021 Net Sales at Rs 4.43 crore, up 192.99% Y-o-Y

 NULL
31-01-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Deviation(S) Or Variation(S) For The Quarter Ended 31St December, 2021 Under Regulation 32 Of SEBI (LODR) Regulations, 2015

 With reference to the above subject, please find enclosed statement confirming that there were no deviation(s) or variation(s) in the use of proceeds, from the objects for which funds were raised through the preferential issue made by the Company, for the quarter ended 31st December, 2021. We request you to take this on your record.
31-01-2022
Next Page
Close

Let's Open Free Demat Account